Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$153,767,389
+$36,754,725 QoQ
Shares Held
611,061
+13.6% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#189
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2026CallValue
$18,369,720
CallShares
73,000
PutValue
$2,516,400
PutShares
10,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TORONTO DOMINION BANK holds $1,118,866,899 across 11 Drug Manufacturers - General names. ABBV ranks #4 (13.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
242,914 | $291,358,362 | |
| 2 | JNJ |
Johnson & Johnson
|
761,198 | $193,321,455 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,468,613 | $188,716,770 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
611,061 | $153,767,389 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
952,712 | $120,365,632 | |
| 6 | AMGN |
Amgen Inc
|
181,652 | $65,779,821 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
926,930 | $53,409,706 | |
| 8 | PFE |
Pfizer Inc
|
1,756,923 | $42,306,705 |
All Filings in ABBV
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,516,400 | 10,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $153,767,389 | 611,061 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $18,369,720 | 73,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $2,174,900 | 10,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $117,012,664 | 538,014 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $34,273,500 | 150,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $2,284,900 | 10,000 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $246,962,958 | 1,080,848 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,315,400 | 10,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $104,193,000 | 450,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $201,122,588 | 868,630 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $158,934,710 | 856,237 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $136,838,138 | 653,103 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $497,560 | 2,800 | Call | Sole | 2025-02-19 | |
| 2024-12-31 | $136,401,097 | 767,592 | Shares | Defined | 2025-02-19 | |
| 2024-09-30 | $137,816,747 | 697,877 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $161,460,521 | 941,351 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $196,364,984 | 1,078,336 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $163,637,781 | 1,055,932 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $154,801,640 | 1,038,519 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $144,405,229 | 1,071,812 | Shares | Sole | 2024-02-14 | |
| 2023-03-31 | $171,082,897 | 1,073,495 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $162,136,039 | 1,003,255 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $112,055,283 | 834,925 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $149,523,521 | 976,257 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $181,224,064 | 1,117,908 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $150,166,993 | 1,109,062 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $136,588,659 | 1,266,234 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $97,885,509 | 869,012 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $103,484,291 | 956,240 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $128,735,259 | 1,201,449 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $96,005,033 | 1,096,073 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $122,532,959 | 1,248,044 | Shares | Sole | 2020-08-28 | |
| 2020-03-31 | $88,920,510 | 1,167,089 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||